CO4990983A1 - CYCLLOALKYL BENZAMIDES STIMULATING HIGH AND LOW GASTROINTESTINAL MOTRICITY - Google Patents

CYCLLOALKYL BENZAMIDES STIMULATING HIGH AND LOW GASTROINTESTINAL MOTRICITY

Info

Publication number
CO4990983A1
CO4990983A1 CO98042279A CO98042279A CO4990983A1 CO 4990983 A1 CO4990983 A1 CO 4990983A1 CO 98042279 A CO98042279 A CO 98042279A CO 98042279 A CO98042279 A CO 98042279A CO 4990983 A1 CO4990983 A1 CO 4990983A1
Authority
CO
Colombia
Prior art keywords
alkyl group
branched
linear
cyclloalkyl
motricity
Prior art date
Application number
CO98042279A
Other languages
Spanish (es)
Inventor
Christian Jeanpetit
Thierry Bouyssou
Helene Christinaki
Serge Biosa
Boucheix Olivier
Original Assignee
Logeais Labor Jacques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Logeais Labor Jacques filed Critical Logeais Labor Jacques
Publication of CO4990983A1 publication Critical patent/CO4990983A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compuestos de fórmula general 1:Caracterizado porque:- R1 es un grupo alquilo linear, ramificado o ciclizado en C1 a C6 o un grupo cicloalquilo en C3 a C6 , dicho grupo alquilo pudiendo, dado el caso, formar un ciclo de 4 a 5 átomos de carbono en el ciclo, en asociación con el carbono en posición 3 del ciclo aromático, y con el cual portan el átomo de oxígeno. - R2 es H, un grupo alquilo en C1 a C6 , lineal o ramificado, OH, o un grupo hidroxialquílico, en el cual el grupo alquilo está en C1 a C4 lineal o ramificado. - R3 es H, un grupo alquilo en C1 a C6 lineal o ramificado, OH o un grupo de hidroxialquilico en el cual el grupo alquilo está en C1 a C4 linear o ramificado, bajo reserva que R2 y R3 no puedan representar simultáneamente a OH. -m = 1 ó 2; -n = 1, 2 ó 3.Compounds of general formula 1: Characterized in that: - R1 is a linear, branched or cyclized alkyl group at C1 to C6 or a cycloalkyl group at C3 to C6, said alkyl group being able, if appropriate, to form a cycle of 4 to 5 atoms carbon in the cycle, in association with carbon in position 3 of the aromatic cycle, and with which they carry the oxygen atom. - R2 is H, a linear or branched C1 to C6 alkyl group, OH, or a hydroxyalkyl group, in which the alkyl group is linear or branched C1 to C4. - R3 is H, a linear or branched C1 to C6 alkyl group, OH or a hydroxyalkyl group in which the linear or branched C1 to C4 alkyl group, subject to the fact that R2 and R3 cannot simultaneously represent OH. -m = 1 or 2; -n = 1, 2 or 3.

CO98042279A 1997-07-25 1998-07-24 CYCLLOALKYL BENZAMIDES STIMULATING HIGH AND LOW GASTROINTESTINAL MOTRICITY CO4990983A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9709478A FR2766486B1 (en) 1997-07-25 1997-07-25 HIGH AND LOW GASTROINTESTINAL MOTOR STIMULATING BENZAMIDE CYCLOALKYLES

Publications (1)

Publication Number Publication Date
CO4990983A1 true CO4990983A1 (en) 2000-12-26

Family

ID=9509624

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98042279A CO4990983A1 (en) 1997-07-25 1998-07-24 CYCLLOALKYL BENZAMIDES STIMULATING HIGH AND LOW GASTROINTESTINAL MOTRICITY

Country Status (8)

Country Link
EP (1) EP0998469A1 (en)
AR (1) AR014901A1 (en)
AU (1) AU8867998A (en)
CO (1) CO4990983A1 (en)
FR (1) FR2766486B1 (en)
TN (1) TNSN98137A1 (en)
WO (1) WO1999005133A1 (en)
ZA (1) ZA986632B (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1015921A (en) * 1961-10-06 1966-01-05 Benger Lab Ltd Benzamides
AR216043A1 (en) * 1974-03-21 1979-11-30 Anphar Sa PROCEDURE FOR THE PREPARATION OF 1-BENZOYLAMINE-4-PIPERIDINE DERIVATIVES AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS
EP0222533A1 (en) * 1985-10-25 1987-05-20 The Upjohn Company Cis-N-[(2-aminocycloaliphatic)benzene acetamide and -benzamide anticonvulsants
FR2674849B1 (en) * 1991-04-02 1994-12-23 Logeais Labor Jacques NOVEL N-CYCLOHEXYL BENZAMIDES OR THIOBENZAMIDES DERIVATIVES, THEIR PREPARATIONS AND THEIR THERAPEUTIC APPLICATIONS.
WO1996005166A1 (en) * 1994-08-11 1996-02-22 Yamanouchi Pharmaceutical Co., Ltd. Substituted amine derivative and medicinal composition containing the same
FR2735693B1 (en) * 1995-06-23 1997-09-26 Logeais Labor Jacques NEW THERAPEUTIC APPLICATIONS OF N-CYCLOHEXYL BENZAMIDES

Also Published As

Publication number Publication date
FR2766486A1 (en) 1999-01-29
ZA986632B (en) 1999-02-04
EP0998469A1 (en) 2000-05-10
TNSN98137A1 (en) 2005-03-15
FR2766486B1 (en) 1999-09-17
AU8867998A (en) 1999-02-16
AR014901A1 (en) 2001-04-11
WO1999005133A1 (en) 1999-02-04

Similar Documents

Publication Publication Date Title
ES2183526T3 (en) DERIVATIVES OF FATTY ACIDS OF BILIARY ACIDS AND DERIVATIVES OF BILIAR ACID.
AR002043A1 (en) USE OF ALPHA AGONISTS (1L) FOR THE TREATMENT OF URINARY INCONTINENCE.
BR0203650A (en) Self-articulating stretcher
HUP0204372A2 (en) Pharmaceutical compositions providing enhanced drug concentrations
ATE300953T1 (en) USE OF PHARMACEUTICAL COMPOUNDS CONTAINING FACTOR VII-A AND FACTOR XIII
BR9809342A (en) Compound, pharmaceutical composition, and use of the compound
ECSP034914A (en) "AZAINDOLS"
ES2104090T3 (en) NEW 3 ', 5'-DI-T-BUTIL-4'-HIDROXI-FLAVONAS, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES2058541T3 (en) A FLAME RETARDANT AND A FLAME RETARDANT RESIN COMPOSITION.
TR200202030T2 (en) The use of IL-18 inhibitors.
DE69231298T2 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
BR0210915A (en) Chimeric Somatostatin-Dopamine Analogs
ATE297945T1 (en) GLUTATHIONE DERIVATIVES AND ASSOCIATED DOSAGE FORMS
DE69435120D1 (en) A vascular smooth muscle cell inhibitor for therapeutic use
UY27244A1 (en) USE OF ACID- (4´-TRIFLUORMETHYLPHENYL) - AMIDA (Z) -2- CYANO-3- HYDROXI-BUT-2-ENOIC FOR THE TREATMENT OF MULTIPLE SCLEROSIS
AR012878A1 (en) A COMPOUND DERIVED FROM 5'-DEOXICITIDINE, ITS USE, A PROCESS TO MANUFACTURE IT, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND IT, AND A KIT THAT INCLUDES SUCH COMPOSITION.
MX9206150A (en) ANTI-INFLAMMATORY AGENTS OF TRIPEPTIDE DERIVATIVES
ECSP930949A (en) DERIVATIVES OF 2- IMIDAZOLINE -5- ONAS AND 2- IMIDAZOLINE- 5 TIONAS FUNGICIDES
ATE7107T1 (en) AGENT FOR THE TREATMENT OF ULCERATIVE COLITIS, REGIONAL ENTERITIS OF CROHN (CROHN'S DISEASE), CHRONIC NON-SPECIFIC COLITIS AND DIVERTICULITIS, AND USE OF SALICYLAZOBENZO ACIDS TO MANUFACTURE SUCH AGENT.
ES2150907T3 (en) AMINO ACID DERIVATIVES.
HN2002000235A (en) FORMULATIONS IN COMBINATION OF DERIVATIVES OF 1, 4 - BENZOTHYPINE - 1, 1 - DIOXIDE WITH OTHER ACTIVE SUBSTANCES, AND THEIR USE
CO4990983A1 (en) CYCLLOALKYL BENZAMIDES STIMULATING HIGH AND LOW GASTROINTESTINAL MOTRICITY
ES2146643T3 (en) FENILCARBOXAMIDA-ISOXAZOLES AND ITS SALTS, ITS PREPARATION PROCEDURE, ITS APPLICATION AS DRUGS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
ATE194282T1 (en) L-ARGININE AND ANALOGUES AS THROMBOCYTE AGGREGATION INHIBITORS
GT199500039AA (en) ARYLTIUM COMPOUNDS